Research location

Beuvry

France

Published trials38

Site observations41

Linked trials published38

Page1 / 1

Research activity in Beuvry

France

CureCurrent currently publishes aggregate city-level research activity for this location: 38 trials and 41 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Beuvry

38 linked trials · page 1 of 1

Arm Swelling Occurence in Breast Cancer Patients With Nodal Radiotherapy: Impact of Informing Them of AI-predicted RiskNCT07187726 · 2025-10-07 · 1 site observation

Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)NCT05512364 · 2023-12-15 · 1 site observation

Evaluation of the Impact of Taking American Ginseng for 8 Weeks on Fatigue in Patients Treated for Localized Breast or Gynecological CancerNCT05241405 · 2022-09-27 · 1 site observation

ADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)NCT04916613 · 2022-04-19 · 1 site observation

Individual Factors Associated With Care Pathways Delays in Breast Cancer in Hauts-de-France.NCT07475325 · 2026-04-20 · 1 site observation

ACTIVE_NOT_RECRUITING

Telemonitoring Platform "CUREETY TECHCARE" vs Standard of Care for mTBNC Patients Initiating a First-line TreatmentNCT06505018 · 2024-07-25 · 1 site observation

Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)NCT05308966 · 2022-05-03 · 1 site observation

Standard Treatment +/- SBRT in Solid Tumors Patients With Between 1 and 5 Bone-only MetastasesNCT03143322 · 2018-07-24 · 2 site observations

ACTIVE_NOT_RECRUITING

PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung CancerNCT03774732 · 2018-01-24 · 2 site observations

ACTIVE_NOT_RECRUITING

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate CancerNCT02799706 · 2017-09-25 · 1 site observation

ACTIVE_NOT_RECRUITING

Impact of Emotional Skills of Young Women and Their Partner on Adjustment to CancerNCT02861742 · 2016-07-25 · 1 site observation

A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer ParticipantsNCT02813408 · 2016-05-03 · 1 site observation

An Observational Study of the Safety of Herceptin Given Subcutaneously in Patients With Early HER2-positive Breast CancerNCT02286362 · 2015-01-14 · 1 site observation

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk ChemotherapyNCT02178475 · 2014-07-18 · 1 site observation

A Phase III Study for Patients With Metastatic Hormone-naïve Prostate CancerNCT01957436 · 2013-11-13 · 1 site observation

ACTIVE_NOT_RECRUITING

An Observational Study of Avastin (Bevacizumab) in Elderly Patients With Non-Squamous Non-Small Cell Lung Cancer in Clinical PracticeNCT01893268 · 2013-07-25 · 1 site observation

Phase II Study of Docetaxel +/- Nintedanib in Breast CancerNCT01658462 · 2013-05-01 · 1 site observation

Psychosocial Support to Facilitate the Return to Employment of Women With Breast CancerNCT01780064 · 2013-02-01 · 1 site observation

PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung CancerNCT01659970 · 2012-06-01 · 1 site observation

A Study to Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)NCT01202188 · 2010-09-01 · 1 site observation

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic or Recurrent Non-Squamous Non-Small Cell Lung CancerNCT01333007 · 2010-07-01 · 1 site observation

Psychometric Validation (Quality-of-life Scale) in Young Women With a Non Metastatic Breast Cancer and Her PartnerNCT02858063 · 2010-01-11 · 1 site observation

Factors Determining Quality of Life Related to Respiratory Status According to Gender of Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT01007734 · 2009-10-01 · 1 site observation

A Study of Whole Brain Radiation Therapy and Capecitabine in Breast Cancer Participants With Newly Diagnosed Brain MetastasisNCT00977379 · 2009-08-01 · 1 site observation

A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD)NCT00900731 · 2009-06-01 · 1 site observation

Epidemiological Study to Describe NSCLC Clinical Management Patterns in Europe. Lung-EPICLINNCT00831909 · 2009-01-01 · 1 site observation

Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT00615030 · 2008-01-01 · 1 site observation

Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active ControlNCT00567996 · 2007-11-01 · 1 site observation

Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPDNCT00530842 · 2007-09-01 · 2 site observations

Tysabri Observational ProgramNCT00493298 · 2007-06-29 · 1 site observation

Cancer Vaccine Study for Unresectable Stage III Non-small Cell Lung Cancer (START)NCT00409188 · 2007-01-01 · 1 site observation

Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)NCT00424268 · 2007-01-01 · 1 site observation

Efficacy, Safety, and Tolerability of Once Daily Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily as Active ControlNCT00393458 · 2006-10-01 · 1 site observation

A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD)NCT00363896 · 2006-07-01 · 1 site observation

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)NCT00313209 · 2006-04-01 · 1 site observation

Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)NCT00297102 · 2006-02-01 · 1 site observation

A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)NCT00239421 · 2003-11-01 · 1 site observation

Tiotropium / Respimat One-Year StudyNCT00168844 · 2003-01-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.